| ₹ crore | Q2 FY27 | Q2 FY26 | Change |
|---|---|---|---|
| Revenue | 7,364 | 6,872 | +7.2% |
| EBITDA | 413 | 657 | −37.0% |
| EBITDA margin | 5.6% | 9.6% | −3.9 pts |
| Profit before tax | 164 | 469 | −65.0% |
| Net profit | 121 | 342 | −64.6% |
| EPS | ₹1.16 | ₹3.30 | −64.8% |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 13,914 | — | — | — | — | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 428 | 381 | 1,143 | 90.7 | 43.0 | ||
| 6,906 | 6,906 | 4,358 | 4,014 | 4,648 | ||
| 20,392 | — | — | — | — | ||
| 23,939 | 21,826 | 13,820 | 11,575 | 13,341 | ||
| — | +57.9% | +19.4% | −13.2% | — | ||
| 2,049 | 2,152 | 1,256 | 648 | 801 | ||
| 8.6% | 9.9% | 9.1% | 5.6% | 6.0% | ||
| 1,606 | 1,749 | 1,004 | 437 | 626 | ||
| 851 | 996 | 552 | 101 | 304 | ||
| 3.6% | 4.6% | 4.0% | 0.9% | 2.3% | ||
| ₹8.20 | ₹9.60 | ₹5.32 | ₹0.97 | ₹2.93 | ||
| — | +80.6% | +448.6% | −66.9% | — | ||
| — | −1,012 | 1,386 | 1,437 | −2,377 | ||
| — | −868 | −369 | −412 | −436 | ||
| −1,880 | −1,880 | 1,017 | 1,025 | −2,813 | ||
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|---|---|
| Market Capitalization | — | — | — | — | 13,913.6 | |
| - Cash, Equiv & ST Investments | 43.0 | 90.7 | 1,142.8 | 381.2 | 427.9 | |
| + Total Debt | 4,647.9 | 4,013.7 | 4,358.5 | 6,906.3 | 6,906.3 | |
| Enterprise Value | — | — | — | — | 20,391.9 | |
| Revenue | 13,340.7 | 11,575.1 | 13,820.2 | 21,826.3 | 23,939.0 | |
| Growth %, YoY | — | -13.2 | +19.4 | +57.9 | — | |
| EBITDA | 801.0 | 648.0 | 1,255.8 | 2,152.3 | 2,048.6 | |
| Margin % | 6.00 | 5.60 | 9.09 | 9.86 | 8.56 | |
| EBIT | 625.8 | 437.4 | 1,004.0 | 1,749.1 | 1,606.3 | |
| Net Income | 304.2 | 100.6 | 551.8 | 996.4 | 851.2 | |
| Margin % | 2.28 | 0.87 | 3.99 | 4.56 | 3.56 | |
| EPS, Adj (current shares) | 2.93 | 0.97 | 5.32 | 9.60 | 8.20 | |
| Growth %, YoY | — | -66.9 | +448.6 | +80.6 | — | |
| Cash from Operations | -2,376.7 | 1,436.8 | 1,386.0 | -1,011.9 | — | |
| Capital Expenditures | -436.2 | -411.5 | -368.7 | -867.8 | — | |
| Free Cash Flow | -2,812.9 | 1,025.3 | 1,017.4 | -1,879.7 | -1,879.7 | |
Prices at the 30 October 2026 close · figures from the company's filings with NSE
Paradeep Phosphates (NSE: PARADEEP) had a market capitalisation of ₹13,407 crore at the 30 October 2026 close (₹129.10 a share), a PE ratio of 15.8 on the last four quarters' profit and a price-to-book ratio of 1.88. In FY26 its consolidated net profit was ₹996 crore on revenue of ₹21,826 crore; in Q2 FY27 (July–September 2026) it was ₹121 crore, down 64.6% year on year. Its debt-to-equity ratio was 1.38 on 30 September 2026. Promoters held 57.85% of the shares on 30 September 2026.
Paradeep Phosphates' PE ratio is 15.8 at the 30 October 2026 close (₹129.10 a share): a market capitalisation of ₹13,407 crore divided by consolidated net profit of ₹851 crore over the last four quarters (Q3 FY26 to Q2 FY27). On FY26 net profit (₹996 crore) it is 13.5.
Paradeep Phosphates' price-to-book (PB) ratio is 1.88 at the 30 October 2026 close: a market capitalisation of ₹13,407 crore divided by shareholders' equity (book value) of ₹7,145 crore on 30 September 2026. That is a book value of ₹68.80 per share against a share price of ₹129.10.
Paradeep Phosphates' net worth — shareholders' equity in its consolidated balance sheet — was ₹7,145 crore on 30 September 2026, up 11.0% from ₹6,438 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹13,407 crore at the 30 October 2026 close.
Paradeep Phosphates' market capitalisation was ₹13,407 crore at the 30 October 2026 close: 103.85 crore shares at ₹129.10 each.
Paradeep Phosphates' basic earnings per share (EPS) were ₹9.60 in FY26, against ₹6.77 in FY25.
In 2026, Paradeep Phosphates has declared one dividend: ₹1.50 with record date 4 September 2026.
No. Paradeep Phosphates had borrowings of ₹9,879 crore on 30 September 2026 (consolidated balance sheet), a debt-to-equity ratio of 1.38. Its cash and current investments were ₹481 crore, so its net debt was ₹9,398 crore.
Paradeep Phosphates' debt-to-equity ratio was 1.38 on 30 September 2026: borrowings of ₹9,879 crore against total equity of ₹7,145 crore. A year earlier, on 30 September 2025, it was 0.87.
Paradeep Phosphates' book value per share was ₹68.80 on 30 September 2026: shareholders' equity of ₹7,145 crore divided by the 103.85 crore shares in issue. The share price at the 30 October 2026 close was ₹129.10.
In FY26, Paradeep Phosphates' return on equity (ROE) was 18.4% and its return on capital employed (ROCE) was 27.0%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 14.4% and ROCE 21.5%.
Promoters held 57.85% of Paradeep Phosphates on 30 September 2026, down 0.01 percentage points from 57.86% the previous quarter and up 0.65 percentage points from 57.20% a year earlier, according to the shareholding pattern filed with NSE.
At the 30 October 2026 closing prices, on FY26 net profit, Paradeep Phosphates' PE ratio is 13.5, the second highest of the three: Coromandel International 25.6 and Chambal Fertilizers & Chemicals 7.3, a peer average of 16.4. Each is the company's market capitalisation at that price divided by its FY26 net profit.
On 30 September 2026, Paradeep Phosphates' shares were held by promoters 57.85%, foreign portfolio investors (FII/FPI) 4.79%, domestic institutions (DII) 20.26% (including mutual funds at 19.86%) and retail and other non-institutional investors 17.00%. Over the year, FII holding was down 10.22 percentage points from 15.01% and DII holding was up 5.69 percentage points from 14.57%.
In FY26, Paradeep Phosphates generated ₹1,012 crore of cash from operations and spent ₹868 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of −₹1,880 crore. In FY25 it was ₹1,017 crore.
Paradeep Phosphates' latest results are for Q2 FY27 (July–September 2026), filed on 29 October 2026: consolidated net profit ₹121 crore, down 64.6% from ₹342 crore in Q2 FY26; revenue from operations ₹7,364 crore, up 7.2% year on year.
In FY26 (April 2025–March 2026), Paradeep Phosphates' consolidated net profit was ₹996 crore, up 80.6% from ₹552 crore in FY25, on revenue from operations of ₹21,826 crore (up 57.9%). Over three years, from FY23, net profit was up 227.6%.
Paradeep Phosphates has reported Q2 FY27. Its next results, for Q3 FY27 (October–December 2026), are due by 14 February 2027 under SEBI's 45-day rule; the company notifies the board-meeting date at least two working days before.
In FY26, Paradeep Phosphates earned net profit of ₹996 crore on revenue of ₹21,826 crore, against ₹1,956 crore on ₹31,480 crore for Coromandel International. Paradeep Phosphates' operating margin was 8.0% (Coromandel International 8.5%) and its return on equity 18.4% (Coromandel International 16.6%). At the 30 October 2026 close, Paradeep Phosphates' market capitalisation was ₹13,407 crore against ₹50,032 crore for Coromandel International, and its PE ratio on FY26 profit 13.5 against 25.6.
On FY26 consolidated figures, against Coromandel International and Chambal Fertilizers & Chemicals: Paradeep Phosphates' operating margin of 8.0% is the lowest of the three (Coromandel International 8.5%, Chambal Fertilizers & Chemicals 11.2%; peer average 9.9%); its return on equity of 18.4% is the second highest of the three (Coromandel International 16.6%, Chambal Fertilizers & Chemicals 20.4%; peer average 18.5%); its revenue growth over three years of 17.8% a year is the highest of the three (Coromandel International 2.0% a year, Chambal Fertilizers & Chemicals −9.2% a year; peer average −3.6% a year).
From Paradeep Phosphates' own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 30 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.